Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,2614685,EC(50),"The normotensive group of rabbits had a calculated EC(50) of 12.7 ng/ml, while the hypertensive group had an EC(50) of 6.9 ng/ml, indicating that the hypertensive rabbits were much more sensitive to the propranolol than the normotensive group.",Effect of propranolol on the myocardial contractility of normotensive and spontaneously hypertensive rabbits: relationship of pharmacokinetics and pharmacodynamics. ,EC50-Q16,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2614685/),[ng] / [ml],12.7,1518,DB00723,Methoxamine
,2614685,EC(50),"The normotensive group of rabbits had a calculated EC(50) of 12.7 ng/ml, while the hypertensive group had an EC(50) of 6.9 ng/ml, indicating that the hypertensive rabbits were much more sensitive to the propranolol than the normotensive group.",Effect of propranolol on the myocardial contractility of normotensive and spontaneously hypertensive rabbits: relationship of pharmacokinetics and pharmacodynamics. ,EC50-Q16,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2614685/),[ng] / [ml],6.9,1519,DB00723,Methoxamine
,24499493,Tmax,Tmax was at ~4.5 h post-dose for all NRL001 doses.,Randomised clinical trial: study of escalating doses of NRL001 given in rectal suppositories of different weights. ,tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24499493/),h,4.5,149949,DB00723,Methoxamine
,24499495,Tmax,"AUC and Cmax broadly increased with increasing dose, Tmax generally occurred between 4.0 and 5.0 h.","A double-blind, placebo-controlled, randomised, parallel-group, dose-escalating, repeat dose study in healthy volunteers to evaluate the safety, tolerability, pharmacodynamic effects and pharmacokinetics of the once daily rectal application of NRL001 suppositories for 14 days. ",tmax-Q56,[Article Link](https://pubmed.ncbi.nlm.nih.gov/24499495/),h,4.0 and 5.0,184162,DB00723,Methoxamine
,17766197,t1/2,"The t1/2 values of the three drugs in rats were found to be 5.38+/-0.61, 4.49+/-0.53, and 3.70+/-0.19 h for MXL, MTX, and MTR, respectively.","Pharmacokinetic study of three cardiovascular drugs by high-performance liquid chromatography using pre-column derivatization with 9,10-anthraquinone-2-sulfonyl chloride. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/17766197/),h,5.38,273966,DB00723,Methoxamine
,17766197,t1/2,"The t1/2 values of the three drugs in rats were found to be 5.38+/-0.61, 4.49+/-0.53, and 3.70+/-0.19 h for MXL, MTX, and MTR, respectively.","Pharmacokinetic study of three cardiovascular drugs by high-performance liquid chromatography using pre-column derivatization with 9,10-anthraquinone-2-sulfonyl chloride. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/17766197/),h,4.49,273967,DB00723,Methoxamine
,17766197,t1/2,"The t1/2 values of the three drugs in rats were found to be 5.38+/-0.61, 4.49+/-0.53, and 3.70+/-0.19 h for MXL, MTX, and MTR, respectively.","Pharmacokinetic study of three cardiovascular drugs by high-performance liquid chromatography using pre-column derivatization with 9,10-anthraquinone-2-sulfonyl chloride. ",t1/2-Q57,[Article Link](https://pubmed.ncbi.nlm.nih.gov/17766197/),h,3.70,273968,DB00723,Methoxamine
